Key statistics
As of last trade NuCana PLC (N04:FRA) traded at 1.48, 7.25% above its 52-week low of 1.38, set on Nov 11, 2024.
52-week range
Open | 1.48 |
---|---|
High | 1.48 |
Low | 1.48 |
Bid | 1.51 |
Offer | 1.53 |
Previous close | 1.44 |
Average volume | 1.50k |
---|---|
Shares outstanding | 90.66k |
Free float | 67.99k |
P/E (TTM) | -- |
Market cap | 3.63m USD |
EPS (TTM) | -224.68 USD |
Data delayed at least 15 minutes, as of Nov 13 2024 07:03 GMT.
More ▼
Announcements
- NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel
- NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States
- NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024
- NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study
- NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update
- NuCana to Present at the Jefferies Global Healthcare Conference
- NuCana to Present at TD Cowen’s 5th Annual Oncology Innovation Summit
- NuCana Reports First Quarter 2024 Financial Results and Provides Business Update
- NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement
- NuCana Announces Completion of ADS Ratio Change
More ▼